PAR Fundamental Analysis - PAREF

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to PAR. PAR was compared to 42 industry peers in the Diversified REITs industry. The financial health of PAR is average, but there are quite some concerns on its profitability. PAR does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

PAR had negative earnings in the past year.

In the past year PAR had a positive cash flow from operations.

In multiple years PAR reported negative net income over the last 5 years.

PAR had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

PAR has a worse Return On Assets (-2.51%) than 83.33% of its industry peers.

The Return On Equity of PAR (-4.82%) is worse than 85.71% of its industry peers.

PAR has a Return On Invested Capital of 0.38%. This is amonst the worse of the industry: PAR underperforms 92.86% of its industry peers.

		Industry Rank	Sector Rank
ROA	-2.51%
ROE	-4.82%
ROIC	0.38%

ROA(3y)-2.83%

ROA(5y)0.03%

ROE(3y)-5.19%

ROE(5y)-0.42%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PAR's Operating Margin of 8.62% is on the low side compared to the rest of the industry. PAR is outperformed by 90.48% of its industry peers.

With a Gross Margin value of 55.19%, PAR is not doing good in the industry: 71.43% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of PAR has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	8.62%
PM (TTM)	N/A
GM	55.19%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.19%

GM growth 5Y0.11%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PAR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

PAR has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, PAR has more shares outstanding

Compared to 1 year ago, PAR has a worse debt to assets ratio.

2.2 Solvency

PAR has an Altman-Z score of 0.92. This is a bad value and indicates that PAR is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of PAR (0.92) is comparable to the rest of the industry.

PAR has a debt to FCF ratio of 10.36. This is a negative value and a sign of low solvency as PAR would need 10.36 years to pay back of all of its debts.

The Debt to FCF ratio of PAR (10.36) is better than 66.67% of its industry peers.

A Debt/Equity ratio of 0.69 indicates that PAR is somewhat dependend on debt financing.

PAR has a better Debt to Equity ratio (0.69) than 61.90% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.69
Debt/FCF	10.36
Altman-Z	0.92

ROIC/WACC0.07

WACC5.28%

2.3 Liquidity

PAR has a Current Ratio of 1.08. This is a normal value and indicates that PAR is financially healthy and should not expect problems in meeting its short term obligations.

PAR has a better Current ratio (1.08) than 80.95% of its industry peers.

PAR has a Quick Ratio of 1.08. This is a normal value and indicates that PAR is financially healthy and should not expect problems in meeting its short term obligations.

PAR's Quick ratio of 1.08 is amongst the best of the industry. PAR outperforms 83.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.08
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 67.21% over the past year.

Looking at the last year, PAR shows a decrease in Revenue. The Revenue has decreased by -9.36% in the last year.

The Revenue has been growing slightly by 2.79% on average over the past years.

EPS 1Y (TTM)67.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%92.81%

Revenue 1Y (TTM)-9.36%

Revenue growth 3Y0.05%

Revenue growth 5Y2.79%

Sales Q2Q%-22.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

PAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

PAR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PAR is more expensive than 78.57% of the companies in the same industry.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of PAR indicates a rather cheap valuation: PAR is cheaper than 85.71% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	7.77
EV/EBITDA	52.05

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

PAR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PAREF

EPA:PAR (8/11/2025, 7:00:00 PM)

38.3

-0.6 (-1.54%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)07-29 2025-07-29

Earnings (Next)10-28 2025-10-28

Inst Owners0.53%

Inst Owner ChangeN/A

Ins Owners64.88%

Ins Owner ChangeN/A

Market Cap58.22M

Analysts80

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend1.5

Dividend Growth(5Y)-17.19%

DP-42.02%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	5.09
P/FCF	7.77
P/OCF	7.51
P/B	0.52
P/tB	0.52
EV/EBITDA	52.05

EPS(TTM)-3.57

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)4.93

FCFY12.87%

OCF(TTM)5.1

OCFY13.32%

SpS7.53

BVpS73.49

TBVpS73.09

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.51%
ROE	-4.82%
ROCE	0.52%
ROIC	0.38%
ROICexc	0.38%
ROICexgc	0.38%
OM	8.62%
PM (TTM)	N/A
GM	55.19%
FCFM	65.47%

ROA(3y)-2.83%

ROA(5y)0.03%

ROE(3y)-5.19%

ROE(5y)-0.42%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.19%

GM growth 5Y0.11%

F-Score3

Asset Turnover0.05

Health

		Industry Rank	Sector Rank
Debt/Equity	0.69
Debt/FCF	10.36
Debt/EBITDA	29.67
Cap/Depr	16.3%
Cap/Sales	2.29%
Interest Coverage	0.3
Cash Conversion	298.96%
Profit Quality	N/A
Current Ratio	1.08
Quick Ratio	1.08
Altman-Z	0.92

F-Score3

WACC5.28%

ROIC/WACC0.07

Cap/Depr(3y)16.53%

Cap/Depr(5y)37.05%

Cap/Sales(3y)1.98%

Cap/Sales(5y)2.84%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)67.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%92.81%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-9.36%

Revenue growth 3Y0.05%

Revenue growth 5Y2.79%

Sales Q2Q%-22.82%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-70.09%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y131.69%

FCF growth 3Y21.93%

FCF growth 5Y5.76%

OCF growth 1Y129.57%

OCF growth 3Y19.28%

OCF growth 5Y6.49%

PAREF (PAR.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens